Article
Improving radiomics-based isocitrate dehydrogenase 1 prediction in glioma patients using semi-supervised machine learning models.
BMC medical imaging - 9 Dec 2025
Ahmadzadeh Amir Mahmoud, Jafarnezhad Amirhossein, Elyassirad Danial, Vatanparast Mahsa, Gheiji Benyamin, Faghani Shahriar
Abstract excerpt
BACKGROUND: Determining isocitrate dehydrogenase (IDH) mutation status in glioma is important for determining prognosis. We aimed to compare supervised and semi-supervised machine learning (ML) models in glioma IDH1 mutation status prediction using magnetic resonance imaging (MRI)-derived radiomics features. METHODS: Images and segmentation masks from several public collections, including ACRIN-FMISO, CPTAC-GBM,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
